CNBX Pharmaceuticals Inc. SEC filings CNBX
CNBX Pharmaceuticals Inc. has 301 filings in SEC EDGAR's recent list, going back to Jan 9, 2006. Its latest annual report, Form 10-K, was filed on Dec 1, 2025 for the period ended Aug 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jun 24, 2026, covering the quarter ended May 31, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (auditor change). The company's fiscal year ends on August 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Jun 17, 2024 | — |
| CORRESP | Letter to the SEC | Jun 6, 2024 | — |
| UPLOAD | Letter from the SEC | May 30, 2024 | — |
| CORRESP | Letter to the SEC | May 21, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2024 | — |
| NT 10-Q | Extension | Apr 15, 2024 | Feb 29, 2024 |
| CORRESP | Letter to the SEC | Apr 10, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 29, 2024 | — |
| RW | Registration withdrawl | Dec 27, 2022 | — |
| EFFECT | Filing | May 17, 2021 | — |
| UPLOAD | Letter from the SEC | May 14, 2021 | — |
| CORRESP | Letter to the SEC | May 14, 2021 | — |
| EFFECT | Filing | Mar 11, 2021 | — |
| CORRESP | Letter to the SEC | Mar 10, 2021 | — |
| CORRESP | Letter to the SEC | Mar 9, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 8, 2021 | — |
| CORRESP | Letter to the SEC | Feb 23, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2021 | — |
| NT 10-Q | Notice of late filing | Jan 14, 2019 | Nov 30, 2018 |
| NT 10-K | Extension | Nov 29, 2017 | Aug 31, 2017 |
| EFFECT | Filing | Apr 21, 2017 | — |
| CORRESP | Letter to the SEC | Apr 19, 2017 | — |
| CORRESP | Letter to the SEC | Apr 7, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 6, 2017 | — |
| NT 10-K | Extension | Nov 29, 2016 | Aug 31, 2016 |
| NT 10-Q | Cannabics pharmaceuticals inc. | Apr 15, 2016 | Feb 29, 2016 |
| UPLOAD | Letter from the SEC | Mar 15, 2016 | — |
| CORRESP | Letter to the SEC | Feb 22, 2016 | — |
| NT 10-Q | Extension | Jan 14, 2016 | Nov 30, 2015 |
| CORRESP | Letter to the SEC | Dec 23, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 1, 2015 | — |
| NT 10-K | Extension | Nov 30, 2015 | Aug 31, 2015 |
| CORRESP | Letter to the SEC | Oct 20, 2015 | — |
| CORRESP | Letter to the SEC | Oct 14, 2015 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2015 | — |
| CORRESP | Letter to the SEC | Aug 19, 2015 | — |
| CORRESP | Letter to the SEC | Jul 28, 2015 | — |
| CORRESP | Letter to the SEC | Jul 10, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 22, 2015 | — |
| CORRESP | Letter to the SEC | May 28, 2015 | — |
| CORRESP | Letter to the SEC | May 15, 2015 | — |
| UPLOAD | Letter from the SEC | May 5, 2015 | — |
| CORRESP | Letter to the SEC | Apr 21, 2015 | — |
| NT 10-Q | Extension | Apr 14, 2015 | Feb 28, 2015 |
| CORRESP | Letter to the SEC | Apr 7, 2015 | — |
| UPLOAD | Letter from the SEC | Mar 23, 2015 | — |
| NT 10-Q | Notice of late filing | Jan 14, 2015 | Nov 30, 2014 |
| NT 10-K | Extension | Dec 1, 2014 | Aug 31, 2014 |
| EFFECT | Filing | Feb 20, 2014 | — |
| CORRESP | Letter to the SEC | Feb 19, 2014 | — |
| UPLOAD | Letter from the SEC | Jan 29, 2014 | — |
| UPLOAD | Letter from the SEC | Jan 3, 2014 | — |
| NT 10-K | Notice of late filing | Nov 29, 2012 | Aug 31, 2012 |
| NT 10-Q | Notification of late filing | Jul 14, 2011 | May 31, 2011 |
| NT 10-Q | Notification of late filing | Jan 14, 2011 | Nov 30, 2010 |
| 10KSB/A | Annual report | Nov 28, 2008 | Aug 31, 2008 |
| 10KSB | Annual report | Nov 26, 2008 | Aug 31, 2008 |
| 10QSB | Quarterly report on form 10qsb | Jul 7, 2008 | Jul 4, 2008 |
| 10QSB | Quarterly report | Apr 14, 2008 | Feb 29, 2008 |
| 10QSB | Quarterly report on form 10qsb | Jan 14, 2008 | Nov 30, 2007 |
| 10KSB/A | Annual report on form 10ksb | Nov 21, 2007 | Aug 31, 2007 |
| 10KSB | Annual report on form 10ksb | Nov 21, 2007 | Aug 31, 2007 |
| 10QSB | Quaterly report on form 10qsb | Jul 9, 2007 | May 31, 2007 |
| 10QSB | Quarterly report on form 10qsb | Apr 12, 2007 | Feb 28, 2007 |
| 10QSB/A | Quarterly report on form 10qsb | Mar 29, 2007 | Nov 30, 2006 |
| 10KSB/A | Annual report on form 10ksb | Mar 29, 2007 | Aug 31, 2006 |
| 8-A12G | Registration of securities on form 8a12g | Jan 16, 2007 | — |
| 10QSB | Quarterly report on form 10qsb | Jan 12, 2007 | Nov 30, 2006 |
| 10KSB | Annual report on form 10ksb | Nov 6, 2006 | Aug 31, 2006 |
| 10QSB | Quarterly report on form 10-qsb | Jul 12, 2006 | May 31, 2006 |
| CORRESP | Letter to the SEC | Apr 12, 2006 | — |
| SB-2/A | Amended registration statement on form sb-2/a | Apr 10, 2006 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2006 | — |
| SB-2/A | Filing | Mar 14, 2006 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2006 | — |
| SB-2 | Filing | Jan 9, 2006 | — |
Showing 76 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CNBX (OTC)
- Fiscal year ends
- August 31
- Incorporated in
- NV
- Headquarters
- Bethesda, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1343009
- Former names
- Cannabics Pharmaceuticals Inc. (until Mar 16, 2022); American Mining Corp (until May 1, 2014); Thrust Energy Corp. (until May 10, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.